Aptevo Therapeutics APVO
NASDAQ APVO
$1.77 +0.01 (+0.57%)
As of: Oct 2, 2026 · 12:12 PM EDT

Aptevo Therapeutics (APVO) Return on Assets [ROA] (2016 - 2026)

Updated

Aptevo Therapeutics (APVO) reported Return on Assets [ROA] of -154.90% for Q2 2026, up 45.59 percentage points from -200.49% a year earlier but down 42.33 percentage points from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Aptevo Therapeutics posted Return on Assets [ROA] of -121.38%, down 2.03 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -88.19 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -119.36% in FY2024 (-60.39 pp), -58.96% in FY2023 (-76.64 pp), 17.68% in FY2022 (+69.35 pp) and -51.67% in FY2021 (-18.48 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -200.49% in Q2 2025 and a high of 53.47% in Q1 2023.
  • Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of -10.44 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2023 (a gain of 110.25 percentage points); the low point was Q1 2024 (a drop of 180.71 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -112.57% (Q1 2026), -96.76% (Q4 2025) and -124.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn - -154.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -154.90%
Mar 31, 2026 -112.57%
Dec 31, 2025 -96.76%
Sep 30, 2025 -124.51%
Jun 30, 2025 -200.49%
Mar 31, 2025 -198.09%
Dec 31, 2024 -157.01%
Sep 30, 2024 -157.79%
Jun 30, 2024 -153.33%
Mar 31, 2024 -127.24%
Dec 31, 2023 -67.01%
Sep 30, 2023 -57.64%
Jun 30, 2023 -54.67%
Mar 31, 2023 53.47%
Dec 31, 2022 24.36%
Sep 30, 2022 18.15%
Jun 30, 2022 16.77%
Mar 31, 2022 -56.78%
Dec 31, 2021 -47.19%
Sep 30, 2021 -43.16%
API Access

Aptevo Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY